Deep Blue

Not a registered adviser. Posts are commentary, not investment advice.

[Deep Blue @deepblueequity]

Peter O'Rourke a former Acting Secretary of the VA (2018) during the #Trump administration, recently joined the board of directors of $QUCY, to assist in building a next-generation defense technology platform. He is recognized as a Trump-era operator with deep Pentagon ties

[Deep Blue @deepblueequity]

@moonmarket https://t.co/S0Yv1GEDhq

[Deep Blue @deepblueequity]

$QUCY
The Pentagon is running a new $1.1 billion drone contest — and it’s turning to startups instead of defense giants
https://t.co/sUDfqNh1sB

[Deep Blue @deepblueequity]

$QUCY
The Pentagon is running a new $1.1 billion drone contest — and it’s turning to startups instead of defense giants
https://t.co/sUDfqNh1sB

[Deep Blue @deepblueequity]

$QUCY
https://t.co/oiTwZn4Pby

[Deep Blue @deepblueequity]

Peter O'Rourke a former Acting Secretary of the VA (2018) during the #Trump administration, recently joined the board of directors of $QUCY, to assist in building a next-generation defense technology platform. He is recognized as a Trump-era operator with deep Pentagon ties

[Deep Blue @deepblueequity]

$QUCY For the win next week

[Deep Blue @deepblueequity]

@moonmarket I'll have fries with that Moon

[Deep Blue @deepblueequity]

@moonmarket Get back to what you do best Moon- set up plays with good DD before they break... set the market-dont chase it

[Deep Blue @deepblueequity]

$SMTK

[Deep Blue @deepblueequity]

$VERU Oppenheimer reiterated an Outperform stock rating and $24.00 price target on Veru, Inc.

[Deep Blue @deepblueequity]

$NVO $VERU Novo Nordisk will buy VERU before the year is over in my opinion...and it they wont come cheap

[Deep Blue @deepblueequity]

@StocksDaily Wegovy is a $20B drug

[Deep Blue @deepblueequity]

$VERU $25 price target from Canaccord

[Deep Blue @deepblueequity]

$VERU
Veru pact with Novo ‘significant event,’ says Canaccord

Canaccord keeps a Buy rating on Veru (VERU) with a $25 price target
https://t.co/f0uRt4PDCV

[Deep Blue @deepblueequity]

$VERU In bed with $NVO on $20 Billion weight drug Wegovy

[Deep Blue @deepblueequity]

$VERU Wegovy is currently a ~$15–$20 billion annualized product

[Deep Blue @deepblueequity]

$VERU Huge deal for this company
52 week high $7.00
https://t.co/b0d1jNMxPk

[Deep Blue @deepblueequity]

@SupNovaTrading yes

[Deep Blue @deepblueequity]

$XOS XOS is now a live short‑squeeze setup.

• Float: ~5 M shares
• Short interest: ~14 %
• Catalyst: Megawatt‑scale Power Hub PR reframing XOS as a data‑center power infrastructure play

[Deep Blue @deepblueequity]

$XOS
Repositioned Into Megawatt‑Scale Grid‑Edge Infrastructure
2.5 MWh Power Hub targets data‑center power shortages
Provides MW‑scale output where the grid cannot
Aligns with hyperscaler + DoD demand for mobile microgrids

Positions XOS inside the AI‑power bottleneck trade

[Deep Blue @deepblueequity]

$YMAT Last big move went to $2.50
With todays PR and AH move this may see some serious momentum tomorrow
On watch

[Deep Blue @deepblueequity]

$XOS Overnight